Deepta Bhattacharya

Deepta Bhattacharya

Oprichter bij Clade Therapeutics, Inc.

Health Technology

Oorsprong van het eerstegraads netwerk van Deepta Bhattacharya

EntiteitType entiteitIndustrie
8
Holding Company Biotechnology 8

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Deepta Bhattacharya via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
College/University

Chad Cowan

Jim Glasheen

Corporate Officer/Principal

Doctorate Degree

Financial Conglomerates

Martin Murphy

Chief Executive Officer

Financial Conglomerates

Martin Murphy

Director/Board Member

Pharmaceuticals: Major

Martin Murphy

Director/Board Member

Biotechnology

Martin Murphy

Chairman

Biotechnology

Martin Murphy

Director/Board Member

AUTOLUS THERAPEUTICS PLC Biotechnology

Martin Murphy

Director/Board Member

Investment Managers

Martin Murphy

Chairman

PEPSICO, INC. Food: Specialty/Candy

Daniel Vasella

Director/Board Member

Miscellaneous Commercial Services

Martin Murphy

Director/Board Member

Medical/Nursing Services

Martin Murphy

Chairman

Biotechnology

Martin Murphy

Chairman

Investment Managers

Martin Murphy

Chief Executive Officer

3I GROUP PLC Investment Managers

Martin Murphy

Corporate Officer/Principal

Pharmaceuticals: Major

Martin Murphy

Director/Board Member

Pharmaceuticals: Major

Martin Murphy

Director/Board Member

Pharmaceuticals: Major

Martin Murphy

Chairman

SYNCONA LIMITED Investment Trusts/Mutual Funds

Martin Murphy

Chief Executive Officer

ACHILLES THERAPEUTICS PLC Pharmaceuticals: Major

Martin Murphy

Director/Board Member

CRISPR THERAPEUTICS AG Biotechnology

Chad Cowan

Founder

College/University

Jim Glasheen

Undergraduate Degree

Major Banks

Jim Glasheen

Director/Board Member

Miscellaneous Commercial Services

Jim Glasheen

Founder

Investment Managers

Jim Glasheen

Private Equity Investor

The University of Texas Southwestern Medical Center College/University

Chad Cowan

Doctorate Degree

University of Kansas College/University

Chad Cowan

Undergraduate Degree

Biotechnology

Leandro Vetcher

Founder

MOMENTA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Martin Murphy

Director/Board Member

Pharmaceuticals: Major

Leandro Vetcher

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Leandro Vetcher

Masters Business Admin

National University of Rosario College/University

Leandro Vetcher

Undergraduate Degree

The Trustees of Columbia University in The City of New York College/University

Leandro Vetcher

Graduate Degree

Chemicals: Specialty

Leandro Vetcher

Founder

Biotechnology

Martin Murphy

Director/Board Member

Investment Managers

Martin Murphy

Corporate Officer/Principal

University of Bern College/University

Daniel Vasella

Doctorate Degree

AMERICAN EXPRESS COMPANY Finance/Rental/Leasing

Daniel Vasella

Director/Board Member

Miscellaneous Commercial Services

Daniel Vasella

Director/Board Member

Miscellaneous Commercial Services

Daniel Vasella

Corporate Officer/Principal

XBIOTECH INC. Biotechnology

Daniel Vasella

Director/Board Member

Biotechnology

Daniel Vasella

Director/Board Member

Pharmaceuticals: Major

Daniel Vasella

Chief Executive Officer

Medical Specialties

Daniel Vasella

Chairman

Miscellaneous Commercial Services

Daniel Vasella

Director/Board Member

Packaged Software

Daniel Vasella

Director/Board Member

Miscellaneous Commercial Services

Daniel Vasella

Corporate Officer/Principal

Pharmaceuticals: Major

Daniel Vasella

Chairman

Sandoz Pharmaceuticals Corp.

Daniel Vasella

Chief Executive Officer

INSEAD College/University

Daniel Vasella

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 23
Verenigd Koninkrijk 19
Zwitserland 6
Argentinië 3
Trinidad en Tobago 2

Sectoraal

Health Technology 21
Finance 11
Consumer Services 9
Commercial Services 7
Consumer Non-Durables 2

Operationeel

Director/Board Member 40
Chairman 16
Chief Executive Officer 12
Founder 10
Corporate Officer/Principal 8
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU